Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?
Publication
, Journal Article
Harrison, RW; Newby, LK
Published in: J Am Heart Assoc
March 5, 2019
See Article by Gibson et al.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
March 5, 2019
Volume
8
Issue
5
Start / End Page
e012014
Location
England
Related Subject Headings
- Treatment Outcome
- Rivaroxaban
- Humans
- Acute Coronary Syndrome
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Harrison, R. W., & Newby, L. K. (2019). Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? J Am Heart Assoc, 8(5), e012014. https://doi.org/10.1161/JAHA.119.012014
Harrison, Robert W., and L Kristin Newby. “Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?” J Am Heart Assoc 8, no. 5 (March 5, 2019): e012014. https://doi.org/10.1161/JAHA.119.012014.
Harrison RW, Newby LK. Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? J Am Heart Assoc. 2019 Mar 5;8(5):e012014.
Harrison, Robert W., and L. Kristin Newby. “Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?” J Am Heart Assoc, vol. 8, no. 5, Mar. 2019, p. e012014. Pubmed, doi:10.1161/JAHA.119.012014.
Harrison RW, Newby LK. Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? J Am Heart Assoc. 2019 Mar 5;8(5):e012014.
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
March 5, 2019
Volume
8
Issue
5
Start / End Page
e012014
Location
England
Related Subject Headings
- Treatment Outcome
- Rivaroxaban
- Humans
- Acute Coronary Syndrome
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology